Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction

Background: The prognostic significance of QRS duration (QRSd) in patients with dilated cardiomyopathy (DCM) and a left ventricular ejection fraction (LVEF) between 30% and 50% is unclear, resulting in questions regarding eligibility for cardiac resynchronisation therapy. This study aimed to explore...

Full description

Bibliographic Details
Main Authors: Jiayu Feng, Xuemei Zhao, Boping Huang, Yihang Wu, Jing Wang, Jingyuan Guan, Liyan Huang, Xinqing Li, Yuhui Zhang, Jian Zhang
Format: Article
Language:English
Published: IMR Press 2023-12-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/24/12/10.31083/j.rcm2412362
_version_ 1797365323667603456
author Jiayu Feng
Xuemei Zhao
Boping Huang
Yihang Wu
Jing Wang
Jingyuan Guan
Liyan Huang
Xinqing Li
Yuhui Zhang
Jian Zhang
author_facet Jiayu Feng
Xuemei Zhao
Boping Huang
Yihang Wu
Jing Wang
Jingyuan Guan
Liyan Huang
Xinqing Li
Yuhui Zhang
Jian Zhang
author_sort Jiayu Feng
collection DOAJ
description Background: The prognostic significance of QRS duration (QRSd) in patients with dilated cardiomyopathy (DCM) and a left ventricular ejection fraction (LVEF) between 30% and 50% is unclear, resulting in questions regarding eligibility for cardiac resynchronisation therapy. This study aimed to explore the prognostic role of QRSd in patients with DCM and a LVEF 30–50% or LVEF <30%. Methods: Patients hospitalised at Fuwai hospital with DCM who had a LVEF ≤50% were prospectively included. The primary outcomes were a composite of death, heart transplantation, and rehospitalisation for worsening heart failure. Results: Among the 633 patients included, 302 (47.7%) had a LVEF of 30–50%. The multivariable hazard ratio (HR) for QRSd ≥120 ms was 1.65 (95% confidence interval [CI] 1.29–2.11, p < 0.001) for overall DCM patients, 2.8 (95% CI 1.82–4.30, p < 0.001) for patients with LVEF 30–50%, and 1.41 (95% CI 1.02–1.94, p = 0.036) for patients with LVEF <30%. QRSd ≥120 ms tended to be more strongly associated with outcome in patients with LVEF 30–50% than in those with LVEF <30% despite the non-significant interaction (p = 0.067). DCM patients with QRSd ≥120 ms and LVEF 30–50% did not experience a significantly better outcome than those with LVEF <30% and QRSd <120 ms after propensity-score matching (HR 0.91, 95% CI 0.61–1.36, p = 0.645). Conclusions: QRSd independently predicts prognosis in DCM patients irrespective of LVEF and identifies a group of high-risk patients who may benefit from device implantation despite the absence of severely reduced LVEF.
first_indexed 2024-03-08T16:47:29Z
format Article
id doaj.art-d8081bc7a78e46b291cede9bc29b82c4
institution Directory Open Access Journal
issn 1530-6550
language English
last_indexed 2024-03-08T16:47:29Z
publishDate 2023-12-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj.art-d8081bc7a78e46b291cede9bc29b82c42024-01-05T09:04:30ZengIMR PressReviews in Cardiovascular Medicine1530-65502023-12-01241236210.31083/j.rcm2412362S1530-6550(23)01097-9Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection FractionJiayu Feng0Xuemei Zhao1Boping Huang2Yihang Wu3Jing Wang4Jingyuan Guan5Liyan Huang6Xinqing Li7Yuhui Zhang8Jian Zhang9State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaState Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 10000 Beijing, ChinaBackground: The prognostic significance of QRS duration (QRSd) in patients with dilated cardiomyopathy (DCM) and a left ventricular ejection fraction (LVEF) between 30% and 50% is unclear, resulting in questions regarding eligibility for cardiac resynchronisation therapy. This study aimed to explore the prognostic role of QRSd in patients with DCM and a LVEF 30–50% or LVEF <30%. Methods: Patients hospitalised at Fuwai hospital with DCM who had a LVEF ≤50% were prospectively included. The primary outcomes were a composite of death, heart transplantation, and rehospitalisation for worsening heart failure. Results: Among the 633 patients included, 302 (47.7%) had a LVEF of 30–50%. The multivariable hazard ratio (HR) for QRSd ≥120 ms was 1.65 (95% confidence interval [CI] 1.29–2.11, p < 0.001) for overall DCM patients, 2.8 (95% CI 1.82–4.30, p < 0.001) for patients with LVEF 30–50%, and 1.41 (95% CI 1.02–1.94, p = 0.036) for patients with LVEF <30%. QRSd ≥120 ms tended to be more strongly associated with outcome in patients with LVEF 30–50% than in those with LVEF <30% despite the non-significant interaction (p = 0.067). DCM patients with QRSd ≥120 ms and LVEF 30–50% did not experience a significantly better outcome than those with LVEF <30% and QRSd <120 ms after propensity-score matching (HR 0.91, 95% CI 0.61–1.36, p = 0.645). Conclusions: QRSd independently predicts prognosis in DCM patients irrespective of LVEF and identifies a group of high-risk patients who may benefit from device implantation despite the absence of severely reduced LVEF.https://www.imrpress.com/journal/RCM/24/12/10.31083/j.rcm2412362dilated cardiomyopathycardiac resynchronization therapyprognosiselectrocardiography
spellingShingle Jiayu Feng
Xuemei Zhao
Boping Huang
Yihang Wu
Jing Wang
Jingyuan Guan
Liyan Huang
Xinqing Li
Yuhui Zhang
Jian Zhang
Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction
Reviews in Cardiovascular Medicine
dilated cardiomyopathy
cardiac resynchronization therapy
prognosis
electrocardiography
title Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction
title_full Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction
title_fullStr Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction
title_full_unstemmed Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction
title_short Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction
title_sort prognostic value of qrs duration in patients with dilated cardiomyopathy according to left ventricular ejection fraction
topic dilated cardiomyopathy
cardiac resynchronization therapy
prognosis
electrocardiography
url https://www.imrpress.com/journal/RCM/24/12/10.31083/j.rcm2412362
work_keys_str_mv AT jiayufeng prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT xuemeizhao prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT bopinghuang prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT yihangwu prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT jingwang prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT jingyuanguan prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT liyanhuang prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT xinqingli prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT yuhuizhang prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction
AT jianzhang prognosticvalueofqrsdurationinpatientswithdilatedcardiomyopathyaccordingtoleftventricularejectionfraction